
Michael A. Laflamme (@UHN_Research) is a leading figure in the development of pluripotent stem cell–derived cardiomyocyte therapies for heart disease. Attend #ISSCR2026 in Montreal this July to hear more about his latest research: ow.ly/PYEm50Yv2Mh

English




















